French biotech companies raised their fair share of funds in 2021 as the industry saw record levels of investments while R&D flourished amid the continuing COVID-19 pandemic, a new survey reveals.
The French biotech industry saw a spate of high-value partnership deals and financings in 2021, supported by strong public funding and a